PHARMACIA AND UPJOHN FDA Approval NDA 050661

NDA 050661

PHARMACIA AND UPJOHN

FDA Drug Application

Application #050661

Documents

Letter2002-09-30
Letter2002-10-11
Label2014-12-10
Letter2014-12-05
Label2019-08-05
Letter2019-08-06
Letter2021-02-11
Label2021-02-17
Letter2022-05-05
Label2022-05-06

Application Sponsors

NDA 050661PHARMACIA AND UPJOHN

Marketing Status

Discontinued001
Discontinued002
Discontinued003

Application Products

001INJECTABLE;INJECTION10MG/VIAL0IDAMYCINIDARUBICIN HYDROCHLORIDE
002INJECTABLE;INJECTION5MG/VIAL0IDAMYCINIDARUBICIN HYDROCHLORIDE
003INJECTABLE;INJECTION20MG/VIAL0IDAMYCINIDARUBICIN HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1990-09-27PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1993-06-29PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1995-04-25PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1996-09-17PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1997-09-11PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1998-04-22PRIORITY
LABELING; LabelingSUPPL7AP2002-09-30STANDARD
LABELING; LabelingSUPPL8AP2002-10-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2000-04-07PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2000-11-21PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL11AP2002-04-02PRIORITY
LABELING; LabelingSUPPL14AP2014-12-04STANDARD
LABELING; LabelingSUPPL15AP2019-08-02STANDARD
LABELING; LabelingSUPPL16AP2021-02-10STANDARD
LABELING; LabelingSUPPL17AP2022-04-27STANDARD

Submissions Property Types

ORIG1Orphan5
SUPPL2Null14
SUPPL3Null14
SUPPL4Null14
SUPPL5Null14
SUPPL6Null14
SUPPL9Null14
SUPPL10Null14
SUPPL11Null14
SUPPL14Null6
SUPPL15Null6
SUPPL16Null6
SUPPL17Null7

CDER Filings

PFIZER
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50661
            [companyName] => PFIZER
            [docInserts] => ["",""]
            [products] => [{"drugName":"IDAMYCIN","activeIngredients":"IDARUBICIN HYDROCHLORIDE","strength":"10MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"IDAMYCIN","activeIngredients":"IDARUBICIN HYDROCHLORIDE","strength":"5MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"IDAMYCIN","activeIngredients":"IDARUBICIN HYDROCHLORIDE","strength":"20MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"02\/10\/2021","submission":"SUPPL-16","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/050661s016lbl.pdf\"}]","notes":""},{"actionDate":"08\/02\/2019","submission":"SUPPL-15","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/050661s015lbl.pdf\"}]","notes":""},{"actionDate":"12\/04\/2014","submission":"SUPPL-14","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/050661s014lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"IDAMYCIN","submission":"IDARUBICIN HYDROCHLORIDE","actionType":"10MG\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"IDAMYCIN","submission":"IDARUBICIN HYDROCHLORIDE","actionType":"5MG\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"IDAMYCIN","submission":"IDARUBICIN HYDROCHLORIDE","actionType":"20MG\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2021-02-10
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.